Rubin Lab

RUBIN’S REFLECTIONS

Follow on Twitter @IBDMD

Message to Dr. Rubin’s Patients Related to COVID-19 Boosters

Dear Friends and Patients, I hope this message finds you well. Please excuse the group nature of this message, but I did want to reach out with the latest update about COVID-19, and vaccinations. If you want to skip right to the booster info, scroll down to #5 below....

Tweetorial to Provide Updates on COVID-19 for Patients with IBD

View Twitter Thread To watch me deliver the full lecture and view the presentation, click here. I recently gave a lecture about COVID-19 and vaccination with specific information for patients with IBD. This lecture was recorded on July 21st, before the CDC issued...

SARS Vaccine and IBD Tweetorial Summary from December 1

SARS Vaccine and IBD Tweetorial Summary from December 1 David T. Rubin View Twitter Thread Here are my thoughts and a few updates about SARS-CoV-2 vaccines, and also about important implications for our IBD patients. Development of multiple SARS-CoV-2 vaccines in the...

Three waves of Illness from the COVID-19 Pandemic

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine I've been thinking about what comes next, and how can we get ahead of this, and propose the following for consideration. I believe that there will be three waves of illness from the...

Pursuing a Gut Feeling: Exploring Immune Cell Trafficking Inhibitors to Treat IBD

Click here to watch Dr. Rubin and Dr. Long review the role of cell trafficking in IBD pathogenesis and how therapies that modulate immune cell trafficking compare with other agents that target the inflammatory response in IBD.

Hospital-stay duration after IBD surgery not linked to sleep, activity

Second-year Pritzker medical student, Yangtian Yi, received Best Abstract in Surgery at AIBD 2019 for his abstract associating length of stay for IBD surgical patients with data collected from wearable devices. His oral presentation and abstract was reported on by...

Dr. David T. Rubin Reflects on How to Avoid the Next Pandemic with WGN’s Steve Dale

Click here to listen to the full interview.

Pregnancy in the Setting of the SARS-CoV-2 Pandemic

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine Dear Colleagues, A lot of concern has recently come up regarding pregnancy in the setting of the SARS-CoV-2 pandemic. Here are some key points I found on this issue: Pregnancy is a state of...

Tweetorial to Clarify the NYT Article From 15 April and Further Explain/Clarify the UK CLARITY IBD Study

Tweetorial to Clarify the NYT Article From 15 April and Further Explain/Clarify the UK CLARITY IBD Study David T. Rubin View Twitter Thread I've previously commented about the CLARITY IBD Study (Kennedy, et al). paper in this forum, but it bears repeating and further...

Long-Duration Vancomycin Linked to Lower Rates of C. diff Recurrence in IBD

Pritzker medical student Donald Lei's manuscript was accepted to the American Journal of Gastroenterology. Reuters Health Information reported on the study with comments by Dr. Rubin. "Our study did in fact demonstrate significantly reduced rates of recurrence...

IBD Drive Time: Dr. David Rubin, MD, on Ozanimod in Ulcerative Colitis

Click here to listen to Dr. Rubin speak with colleagues and IBD Drive Time hosts Raymond Cross, MD and Millie Long, MD on using newly-approved ozanimod in treating ulcerative colitis.

Lee Matricaria’s Story

How to identify, manage patients with high-risk ulcerative colitis

Dr. Rubin discusses his presentation at ACG 2019 in San Antonio on identifying and managing patients with high-risk ulcerative colitis with Healio Gastroenterology. “The importance of knowing who is high risk has to do with your choices of treatment and your...

How should you treat active IBD during the SARS-CoV-2 pandemic?

By David T. Rubin, MD, Professor of Medicine, University of Chicago Medicine (Posted to IBD-circle.within3.com on March 21, 2020) Colleagues, A question that has come up recently is how we should approach treating active IBD during the SARS-CoV-2 pandemic. Here are my...